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background:  Stent underexpansion is the main predictor of in-stent restenosis (ISR) after drug-eluting stent (DES) placement; however, 
the predictors of expansion after restenting an ISR lesion have not been reported.
methods:  ADAPT-DES was a prospective multicenter, real-world registry of 8,582 consecutive pts undergoing successful DES 
implantation. A pre-specified virtual histology intravascular ultrasound (VH-IVUS) sub-study enrolled 2,072 pts; among them, 74 pts had 
ISR lesions that were stratified according to the median final, post-restenting minimum stent area (MSA: 5.7mm2).
results: The duration from the initial stent implantation to the index procedure was 1.7±3.0 yrs, total prior stent length was 23.2±11.7mm, 
and 28.6% of prior stents were DES. Neointimal calcification and calcification outside of the prior stent were observed in 20.3% (15/74) and 
70.3% (52/74) with mean angles of 81.4±34.3° and 112.6±71.4°, respectively. In pts with a smaller final MSA after restenting, the MSA of 
the prior stent was significantly smaller; but % NIH, % dense calcium or necrotic core within the NIH, or arc of neointimal calcification were 
no different compared to pts with a larger final MSA (Table). The final MSA was positively correlated with the MSA of the prior stent (r=0.52, 
p<0.01), not with the % NIH (p=0.14).
Conclusion:  In ISR lesions, stent expansion after restenting was affected mainly by prior stent underexpansion, not by NIH morphology.
Lesions with MSA <median Lesions with MSA >median p-value
Duration from prior stent implantation, yrs 1.5±2.7 2.0±3.2 0.44
Pre MSA, mm2 4.9±1.7 6.7±2.1 <0.01
Pre minimum lumen area (MLA), mm2 2.9±1.1 3.7±1.6 0.02
Pre vessel area at MLA, mm2 13.1±4.4 18. 4±6.3 <0.01
Pre NIH at MLA, % 44.3±21.8 49.8±20.5 0.27
Pre Necrotic core within NIH at MLA, % 18.1±8.6 16.0±9.8 0.35
Pre Dense calcium within NIH at MLA, % 17.1±20.0 11.1±11.6 0.12
Calcium arc within NIH, ° 77.3±38.0 87.5±30.3 0.59
Final MSA, mm2 4.1±1.1 7.8±1.8 0.02
